| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOR1 TBX3 TCF7 CDX2 CDX4 NEUROD2 ZBTB32 HOXD9 NEUROD4 BARHL2 MECOM RUNX2 RUNX1 RUNX3 MUC1 TBX2 | 2.35e-05 | 1459 | 68 | 16 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TBX3 TCF7 CDX2 CDX4 NEUROD2 ZBTB32 HOXD9 NEUROD4 MECOM RUNX2 RUNX1 RUNX3 MUC1 TBX2 | 6.37e-05 | 1244 | 68 | 14 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX3 TCF7 CDX2 CDX4 NEUROD2 ZBTB32 HOXD9 NEUROD4 MECOM RUNX2 RUNX1 RUNX3 MUC1 TBX2 | 8.02e-05 | 1271 | 68 | 14 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TBX3 TCF7 CDX2 CDX4 NEUROD2 ZBTB32 HOXD9 NEUROD4 BARHL2 MECOM RUNX2 RUNX1 RUNX3 TBX2 | 2.43e-04 | 1412 | 68 | 14 | GO:0000981 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 7.68e-04 | 320 | 68 | 6 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 8.46e-04 | 326 | 68 | 6 | GO:0001217 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | NCOR1 TBX3 TCF7 CDX2 CDX4 ZBTB32 HOXD9 ZNF608 MECOM ZNF318 RUNX2 RUNX1 RUNX3 MUC1 PIAS1 LDB2 TBX2 | 8.02e-07 | 1399 | 64 | 17 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | NCOR1 TBX3 TCF7 CDX2 CDX4 ZBTB32 HOXD9 ZNF608 MECOM ZNF318 RUNX2 RUNX1 RUNX3 MUC1 PIAS1 LDB2 TBX2 | 9.22e-07 | 1413 | 64 | 17 | GO:1902679 |
| GeneOntologyBiologicalProcess | T cell differentiation | 2.62e-06 | 382 | 64 | 9 | GO:0030217 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOR1 TBX3 TCF7 CDX2 CDX4 HOXD9 CC2D2A MECOM RUNX2 RUNX1 MAP3K7 PRRC2B TBX2 | 3.41e-06 | 906 | 64 | 13 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOR1 TBX3 TCF7 CDX2 CDX4 HOXD9 CC2D2A MECOM RUNX2 RUNX1 MAP3K7 PRRC2B TBX2 | 4.48e-06 | 929 | 64 | 13 | GO:0009792 |
| GeneOntologyBiologicalProcess | embryonic forelimb morphogenesis | 5.15e-06 | 37 | 64 | 4 | GO:0035115 | |
| GeneOntologyBiologicalProcess | embryo development | SEMA3A NCOR1 TBX3 TCF7 CDX2 CDX4 HOXD9 PCDH15 CC2D2A MECOM RUNX2 RUNX1 MAP3K7 AHDC1 PRRC2B TBX2 | 5.66e-06 | 1437 | 64 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryonic organ development | 8.27e-06 | 561 | 64 | 10 | GO:0048568 | |
| GeneOntologyBiologicalProcess | forelimb morphogenesis | 1.48e-05 | 48 | 64 | 4 | GO:0035136 | |
| GeneOntologyBiologicalProcess | peripheral nervous system neuron development | 1.55e-05 | 16 | 64 | 3 | GO:0048935 | |
| GeneOntologyBiologicalProcess | peripheral nervous system neuron differentiation | 1.55e-05 | 16 | 64 | 3 | GO:0048934 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | NCOR1 TBX3 TCF7 CDX2 CDX4 ZBTB32 HOXD9 ZNF608 RUNX1 RUNX3 PIAS1 LDB2 TBX2 | 1.72e-05 | 1053 | 64 | 13 | GO:0000122 |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 2.78e-05 | 114 | 64 | 5 | GO:0033077 | |
| GeneOntologyBiologicalProcess | ureteric peristalsis | 2.84e-05 | 3 | 64 | 2 | GO:0072105 | |
| GeneOntologyBiologicalProcess | ureter smooth muscle contraction | 2.84e-05 | 3 | 64 | 2 | GO:0014849 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 3.96e-05 | 537 | 64 | 9 | GO:0030098 | |
| GeneOntologyBiologicalProcess | T cell activation | NCOR1 ZNF609 TCF7 ZBTB32 ZNF608 RUNX2 MPZL2 RUNX1 RUNX3 ZAP70 | 5.56e-05 | 701 | 64 | 10 | GO:0042110 |
| GeneOntologyBiologicalProcess | mammary placode formation | 5.66e-05 | 4 | 64 | 2 | GO:0060596 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 6.41e-05 | 713 | 64 | 10 | GO:0048598 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 7.14e-05 | 226 | 64 | 6 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TBX3 ZNF609 CDX2 CDX4 NEUROD2 HOXD9 NEUROD4 BARHL2 MECOM RUNX2 RUNX1 MUC1 LDB2 TBX2 | 7.36e-05 | 1390 | 64 | 14 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of CD8-positive, alpha-beta T cell differentiation | 9.42e-05 | 5 | 64 | 2 | GO:0043378 | |
| GeneOntologyBiologicalProcess | atrioventricular canal morphogenesis | 9.42e-05 | 5 | 64 | 2 | GO:1905222 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 9.64e-05 | 148 | 64 | 5 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 9.64e-05 | 148 | 64 | 5 | GO:0035113 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation | 1.27e-04 | 157 | 64 | 5 | GO:0046632 | |
| GeneOntologyBiologicalProcess | cardiac jelly development | 1.41e-04 | 6 | 64 | 2 | GO:1905072 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | NCOR1 ZNF609 TCF7 EFNA2 ZNF608 RUNX2 MPZL2 RUNX1 RUNX3 ZAP70 | 1.48e-04 | 789 | 64 | 10 | GO:0002521 |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 1.51e-04 | 640 | 64 | 9 | GO:1903131 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.74e-04 | 266 | 64 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | leukocyte activation | PIKFYVE NCOR1 ZNF609 TCF7 ZBTB32 ZNF608 ENPP3 RUNX2 MPZL2 RUNX1 RUNX3 ZAP70 | 2.51e-04 | 1186 | 64 | 12 | GO:0045321 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 2.62e-04 | 8 | 64 | 2 | GO:0098943 | |
| GeneOntologyBiologicalProcess | regulation of CD8-positive, alpha-beta T cell differentiation | 2.62e-04 | 8 | 64 | 2 | GO:0043376 | |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 2.64e-04 | 100 | 64 | 4 | GO:1903510 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 2.73e-04 | 185 | 64 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 2.73e-04 | 185 | 64 | 5 | GO:0035108 | |
| GeneOntologyBiologicalProcess | hemopoiesis | NCOR1 ZNF609 TCF7 EFNA2 ZBTB32 ZNF608 MECOM RUNX2 MPZL2 RUNX1 RUNX3 ZAP70 | 3.33e-04 | 1223 | 64 | 12 | GO:0030097 |
| GeneOntologyBiologicalProcess | mammary gland formation | 3.36e-04 | 9 | 64 | 2 | GO:0060592 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 3.70e-04 | 306 | 64 | 6 | GO:0048863 | |
| GeneOntologyBiologicalProcess | positive regulation of CD8-positive, alpha-beta T cell activation | 4.20e-04 | 10 | 64 | 2 | GO:2001187 | |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 4.74e-04 | 49 | 64 | 3 | GO:0035137 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 4.87e-04 | 750 | 64 | 9 | GO:0048729 | |
| GeneOntologyBiologicalProcess | epithelium development | SEMA3A NCOR1 TBX3 TCF7 CDX2 PCDH15 CC2D2A MECOM RUNX1 RUNX3 MAP3K7 LDB2 TBX2 | 4.93e-04 | 1469 | 64 | 13 | GO:0060429 |
| GeneOntologyBiologicalProcess | glycosaminoglycan metabolic process | 5.46e-04 | 121 | 64 | 4 | GO:0030203 | |
| GeneOntologyBiologicalProcess | positive regulation of gonad development | 6.13e-04 | 12 | 64 | 2 | GO:1905941 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 6.24e-04 | 338 | 64 | 6 | GO:0045165 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 6.33e-04 | 619 | 64 | 8 | GO:0002009 | |
| GeneOntologyBiologicalProcess | limb development | 6.54e-04 | 224 | 64 | 5 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 6.54e-04 | 224 | 64 | 5 | GO:0048736 | |
| GeneOntologyBiologicalProcess | regionalization | 6.83e-04 | 478 | 64 | 7 | GO:0003002 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation | 6.95e-04 | 227 | 64 | 5 | GO:0046631 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | ZNF609 CDX2 NEUROD2 NEUROD4 ADAMTS20 MECOM RUNX2 RUNX1 RUNX3 PIAS1 ZAP70 | 7.05e-04 | 1141 | 64 | 11 | GO:0045597 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 7.23e-04 | 13 | 64 | 2 | GO:0099628 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 7.23e-04 | 13 | 64 | 2 | GO:0098970 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 7.57e-04 | 132 | 64 | 4 | GO:0006022 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 7.60e-04 | 351 | 64 | 6 | GO:0048562 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell differentiation | 7.78e-04 | 58 | 64 | 3 | GO:0045581 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | NCOR1 ZNF609 TCF7 ZBTB32 ZNF608 RUNX2 MPZL2 RUNX1 RUNX3 ZAP70 | 7.96e-04 | 976 | 64 | 10 | GO:0046649 |
| GeneOntologyBiologicalProcess | cell activation | PIKFYVE NCOR1 ZNF609 TCF7 ZBTB32 ZNF608 ENPP3 RUNX2 MPZL2 RUNX1 RUNX3 ZAP70 | 8.39e-04 | 1356 | 64 | 12 | GO:0001775 |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 8.42e-04 | 14 | 64 | 2 | GO:0098953 | |
| GeneOntologyBiologicalProcess | atrioventricular canal development | 8.42e-04 | 14 | 64 | 2 | GO:0036302 | |
| GeneOntologyBiologicalProcess | peristalsis | 9.70e-04 | 15 | 64 | 2 | GO:0030432 | |
| GeneOntologyBiologicalProcess | urinary tract smooth muscle contraction | 9.70e-04 | 15 | 64 | 2 | GO:0014848 | |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell differentiation | 1.04e-03 | 64 | 64 | 3 | GO:0046638 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.05e-03 | 144 | 64 | 4 | GO:0045582 | |
| GeneOntologyBiologicalProcess | ectodermal placode morphogenesis | 1.11e-03 | 16 | 64 | 2 | GO:0071697 | |
| GeneOntologyBiologicalProcess | ectodermal placode formation | 1.11e-03 | 16 | 64 | 2 | GO:0060788 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.19e-03 | 526 | 64 | 7 | GO:0007389 | |
| GeneOntologyBiologicalProcess | anterior/posterior axis specification | 1.24e-03 | 68 | 64 | 3 | GO:0009948 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte differentiation | 1.34e-03 | 70 | 64 | 3 | GO:0045620 | |
| GeneOntologyBiologicalProcess | ectodermal placode development | 1.40e-03 | 18 | 64 | 2 | GO:0071696 | |
| GeneOntologyBiologicalProcess | muscle cell fate commitment | 1.40e-03 | 18 | 64 | 2 | GO:0042693 | |
| GeneOntologyBiologicalProcess | regulation of gonad development | 1.40e-03 | 18 | 64 | 2 | GO:1905939 | |
| GeneOntologyBiologicalProcess | amacrine cell differentiation | 1.40e-03 | 18 | 64 | 2 | GO:0035881 | |
| GeneOntologyBiologicalProcess | stem cell proliferation | 1.41e-03 | 156 | 64 | 4 | GO:0072089 | |
| GeneOntologyBiologicalProcess | regulation of JNK cascade | 1.58e-03 | 161 | 64 | 4 | GO:0046328 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 1.62e-03 | 162 | 64 | 4 | GO:0045621 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SEMA3A TBX3 TCF7 CDX2 CDX4 HOXD9 PCDH15 MECOM RUNX2 AHDC1 TBX2 | 1.67e-03 | 1269 | 64 | 11 | GO:0009887 |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 1.70e-03 | 76 | 64 | 3 | GO:0006024 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 1.77e-03 | 166 | 64 | 4 | GO:0098773 | |
| GeneOntologyBiologicalProcess | CD8-positive, alpha-beta T cell differentiation | 1.92e-03 | 21 | 64 | 2 | GO:0043374 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 1.93e-03 | 421 | 64 | 6 | GO:0048638 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 1.97e-03 | 80 | 64 | 3 | GO:0006023 | |
| GeneOntologyBiologicalProcess | regulation of CD8-positive, alpha-beta T cell activation | 2.10e-03 | 22 | 64 | 2 | GO:2001185 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 2.12e-03 | 429 | 64 | 6 | GO:1902105 | |
| GeneOntologyCellularComponent | chromatin | NCOR1 TBX3 TCF7 CDX2 CDX4 NEUROD2 ZBTB32 HOXD9 NEUROD4 BARHL2 HPF1 RUNX2 RUNX1 RUNX3 MAP3K7 SMCR8 MUC1 PIAS1 TBX2 | 2.45e-07 | 1480 | 70 | 19 | GO:0000785 |
| GeneOntologyCellularComponent | core-binding factor complex | 3.31e-05 | 3 | 70 | 2 | GO:0016513 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.62e-04 | 596 | 70 | 9 | GO:0005667 | |
| MousePheno | limbs/digits/tail phenotype | TBX3 UXS1 TCF7 CDX2 NEUROD2 HOXD9 GLCE HPF1 ADAMTS20 CC2D2A MECOM RUNX2 MPZL2 RUNX3 MAP3K7 SLC29A4 TBX2 | 4.92e-06 | 1258 | 56 | 17 | MP:0005371 |
| MousePheno | abnormal limb morphology | TBX3 UXS1 TCF7 NEUROD2 HOXD9 GLCE HPF1 ADAMTS20 CC2D2A MECOM RUNX2 MPZL2 RUNX3 SLC29A4 TBX2 | 8.31e-06 | 1028 | 56 | 15 | MP:0002109 |
| MousePheno | absent tarsus bones | 1.58e-05 | 2 | 56 | 2 | MP:0009729 | |
| MousePheno | abnormal autopod morphology | 2.22e-05 | 390 | 56 | 9 | MP:0000572 | |
| MousePheno | abnormal digit morphology | 4.03e-05 | 323 | 56 | 8 | MP:0002110 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 8.13e-05 | 263 | 56 | 7 | MP:0011099 | |
| MousePheno | abnormal forelimb morphology | 8.48e-05 | 182 | 56 | 6 | MP:0000550 | |
| MousePheno | pulmonary vascular congestion | 1.16e-04 | 24 | 56 | 3 | MP:0010018 | |
| Domain | Runt | 5.04e-08 | 3 | 70 | 3 | PF00853 | |
| Domain | Runt_dom | 5.04e-08 | 3 | 70 | 3 | IPR013524 | |
| Domain | RunxI_C_dom | 5.04e-08 | 3 | 70 | 3 | IPR013711 | |
| Domain | RUNT | 5.04e-08 | 3 | 70 | 3 | PS51062 | |
| Domain | Runx_central_dom | 5.04e-08 | 3 | 70 | 3 | IPR027384 | |
| Domain | - | 5.04e-08 | 3 | 70 | 3 | 4.10.770.10 | |
| Domain | TF_Runt-rel_RUNX | 5.04e-08 | 3 | 70 | 3 | IPR016554 | |
| Domain | RunxI | 5.04e-08 | 3 | 70 | 3 | PF08504 | |
| Domain | AML1_Runt | 5.04e-08 | 3 | 70 | 3 | IPR000040 | |
| Domain | p53/RUNT-type_TF_DNA-bd | 1.00e-06 | 6 | 70 | 3 | IPR012346 | |
| Domain | - | 1.00e-06 | 6 | 70 | 3 | 2.60.40.720 | |
| Domain | p53-like_TF_DNA-bd | 1.60e-06 | 53 | 70 | 5 | IPR008967 | |
| Domain | TBX | 1.38e-05 | 2 | 70 | 2 | IPR022582 | |
| Domain | TBX | 1.38e-05 | 2 | 70 | 2 | PF12598 | |
| Domain | Caudal_act | 4.14e-05 | 3 | 70 | 2 | PF04731 | |
| Domain | Caudal_activation_dom | 4.14e-05 | 3 | 70 | 2 | IPR006820 | |
| Domain | Neurogenic_DUF | 8.27e-05 | 4 | 70 | 2 | IPR022575 | |
| Domain | Neuro_bHLH | 8.27e-05 | 4 | 70 | 2 | PF12533 | |
| Domain | TF_bHLH_NeuroD | 8.27e-05 | 4 | 70 | 2 | IPR016637 | |
| Domain | HTH_motif | 1.30e-04 | 69 | 70 | 4 | IPR000047 | |
| Domain | Homeobox_metazoa | 3.63e-04 | 90 | 70 | 4 | IPR020479 | |
| Domain | VDCC_gsu | 3.82e-04 | 8 | 70 | 2 | IPR008368 | |
| Domain | NBPF_dom | 7.45e-04 | 11 | 70 | 2 | IPR010630 | |
| Domain | NBPF | 7.45e-04 | 11 | 70 | 2 | PS51316 | |
| Domain | DUF1220 | 7.45e-04 | 11 | 70 | 2 | PF06758 | |
| Domain | TF_T-box | 1.82e-03 | 17 | 70 | 2 | IPR001699 | |
| Domain | TBOX | 1.82e-03 | 17 | 70 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 1.82e-03 | 17 | 70 | 2 | IPR018186 | |
| Domain | - | 1.82e-03 | 17 | 70 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 1.82e-03 | 17 | 70 | 2 | PS50252 | |
| Domain | T-box | 1.82e-03 | 17 | 70 | 2 | PF00907 | |
| Domain | TBOX_1 | 1.82e-03 | 17 | 70 | 2 | PS01283 | |
| Domain | TBOX_2 | 1.82e-03 | 17 | 70 | 2 | PS01264 | |
| Domain | - | 4.18e-03 | 283 | 70 | 5 | 1.10.10.60 | |
| Domain | Homeobox_CS | 5.24e-03 | 186 | 70 | 4 | IPR017970 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 1.83e-04 | 6 | 50 | 2 | MM15542 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.00e-04 | 82 | 50 | 4 | M2 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS | 2.56e-04 | 7 | 50 | 2 | M27799 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 2.98e-04 | 91 | 50 | 4 | M39700 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 3.41e-04 | 8 | 50 | 2 | M27359 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 3.41e-04 | 8 | 50 | 2 | M27821 | |
| Pubmed | 5.04e-09 | 191 | 70 | 8 | 24146773 | ||
| Pubmed | Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development. | 7.81e-09 | 3 | 70 | 3 | 14516670 | |
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 7835892 | ||
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 15713794 | ||
| Pubmed | Genetic regulation of the RUNX transcription factor family has antitumor effects. | 7.81e-09 | 3 | 70 | 3 | 28530640 | |
| Pubmed | Identification and comparative analysis of a second runx3 promoter. | 7.81e-09 | 3 | 70 | 3 | 11483356 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | TBX3 TCF7 CDX2 CDX4 NEUROD2 ZBTB32 HOXD9 BARHL2 RUNX2 RUNX3 TBX2 | 1.17e-08 | 544 | 70 | 11 | 28473536 |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 29107070 | ||
| Pubmed | A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. | 3.12e-08 | 4 | 70 | 3 | 10228168 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 20236534 | ||
| Pubmed | Central Role of Core Binding Factor β2 in Mucosa-Associated Lymphoid Tissue Organogenesis in Mouse. | 3.12e-08 | 4 | 70 | 3 | 26001080 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 20306685 | ||
| Pubmed | The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells. | 3.12e-08 | 4 | 70 | 3 | 25185713 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 12807883 | ||
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 12464175 | ||
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 8437866 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.71e-08 | 351 | 70 | 9 | 38297188 | |
| Pubmed | 7.79e-08 | 5 | 70 | 3 | 35114276 | ||
| Pubmed | Runx3 is required for oncogenic Myc upregulation in p53-deficient osteosarcoma. | 7.79e-08 | 5 | 70 | 3 | 34803166 | |
| Pubmed | 7.79e-08 | 5 | 70 | 3 | 9794229 | ||
| Pubmed | Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. | 7.79e-08 | 5 | 70 | 3 | 17377532 | |
| Pubmed | Interplay between SOX7 and RUNX1 regulates hemogenic endothelial fate in the yolk sac. | 7.79e-08 | 5 | 70 | 3 | 27802172 | |
| Pubmed | 1.55e-07 | 24 | 70 | 4 | 33722704 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 24677539 | ||
| Pubmed | The essential requirement for Runx1 in the development of the sternum. | 1.55e-07 | 6 | 70 | 3 | 20152828 | |
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 23532528 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX3 TCF7 CDX2 CDX4 NEUROD2 HOXD9 NEUROD4 BARHL2 RUNX2 RUNX1 RUNX3 TBX2 | 2.47e-07 | 908 | 70 | 12 | 19274049 |
| Pubmed | Physical and functional link of the leukemia-associated factors AML1 and PML. | 2.72e-07 | 7 | 70 | 3 | 15331439 | |
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 18759297 | ||
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 21088106 | ||
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 24505141 | ||
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 20181744 | ||
| Pubmed | 4.34e-07 | 8 | 70 | 3 | 10531362 | ||
| Pubmed | Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects. | 4.34e-07 | 8 | 70 | 3 | 21807129 | |
| Pubmed | Dominance of SOX9 function over RUNX2 during skeletogenesis. | 4.34e-07 | 8 | 70 | 3 | 17142326 | |
| Pubmed | NCOR1 TBX3 ZNF609 TCF7 CDX2 CDX4 ZNF318 RUNX2 RUNX3 PIAS1 LDB2 | 6.18e-07 | 808 | 70 | 11 | 20412781 | |
| Pubmed | Runx1 contributes to neurofibromatosis type 1 neurofibroma formation. | 6.50e-07 | 9 | 70 | 3 | 26073082 | |
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 20700443 | ||
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 11335109 | ||
| Pubmed | Anterior cleft palate due to Cbfb deficiency and its rescue by folic acid. | 2.20e-06 | 13 | 70 | 3 | 31171577 | |
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 28065741 | ||
| Pubmed | Cbfb2 Isoform Dominates More Potent Cbfb1 and Is Required for Skeletal Development. | 3.49e-06 | 15 | 70 | 3 | 26890219 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15034051 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32180230 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 9233771 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22412390 | ||
| Pubmed | The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer. | 3.99e-06 | 2 | 70 | 2 | 23624936 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 11927536 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17290219 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21455926 | ||
| Pubmed | The caudal-related homeodomain protein Cdx-2/3 regulates glucagon gene expression in islet cells. | 3.99e-06 | 2 | 70 | 2 | 8910549 | |
| Pubmed | RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study. | 3.99e-06 | 2 | 70 | 2 | 26674644 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 33479171 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23076336 | ||
| Pubmed | Development of megakaryoblastic leukaemia in Runx1-Evi1 knock-in chimaeric mouse. | 3.99e-06 | 2 | 70 | 2 | 16761014 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26053522 | ||
| Pubmed | Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells. | 3.99e-06 | 2 | 70 | 2 | 35551452 | |
| Pubmed | Cdx mutant axial progenitor cells are rescued by grafting to a wild type environment. | 3.99e-06 | 2 | 70 | 2 | 20816799 | |
| Pubmed | Expression patterns and prognostic value of RUNX genes in kidney cancer. | 3.99e-06 | 2 | 70 | 2 | 34294773 | |
| Pubmed | Neuroblastoma cell proliferation is sensitive to changes in levels of RUNX1 and RUNX3 protein. | 3.99e-06 | 2 | 70 | 2 | 21640801 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19403666 | ||
| Pubmed | Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesis. | 3.99e-06 | 2 | 70 | 2 | 36759572 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23321257 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 18663147 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25394776 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25989273 | ||
| Pubmed | Identification of sequence variants influencing immunoglobulin levels. | 3.99e-06 | 2 | 70 | 2 | 28628107 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 11731260 | ||
| Pubmed | Complex functional redundancy of Tbx2 and Tbx3 in mouse limb development. | 3.99e-06 | 2 | 70 | 2 | 35506352 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23388722 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30223900 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 8313895 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10468588 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17533052 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26883634 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27634876 | ||
| Pubmed | Coexpression of Runx1 and Runx3 in mechanoreceptive dorsal root ganglion neurons. | 3.99e-06 | 2 | 70 | 2 | 23378040 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17360569 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17475805 | ||
| Pubmed | Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells. | 3.99e-06 | 2 | 70 | 2 | 15688019 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19603429 | ||
| Pubmed | Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. | 3.99e-06 | 2 | 70 | 2 | 16059634 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25371204 | ||
| Pubmed | Identification and expression of a novel 3'-exon of mouse Runx1/Pebp2alphaB/Cbfa2/AML1 gene. | 3.99e-06 | 2 | 70 | 2 | 10903914 | |
| Pubmed | Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater. | 3.99e-06 | 2 | 70 | 2 | 23439753 | |
| Pubmed | 5.20e-06 | 17 | 70 | 3 | 25410786 | ||
| Pubmed | Cbfb regulates bone development by stabilizing Runx family proteins. | 5.20e-06 | 17 | 70 | 3 | 25262822 | |
| Pubmed | 6.23e-06 | 18 | 70 | 3 | 20386744 | ||
| Pubmed | Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. | 6.23e-06 | 18 | 70 | 3 | 26091038 | |
| Pubmed | NCOR1 TBX3 ZNF609 TCF7 ZNF608 TEX264 RUNX2 RUNX1 MAP3K7 PABPC1 AHDC1 NFU1 | 6.67e-06 | 1247 | 70 | 12 | 27684187 | |
| Pubmed | 7.39e-06 | 19 | 70 | 3 | 38795454 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 9.98e-06 | 877 | 70 | 10 | 20211142 | |
| Pubmed | RUNX1 maintains the identity of the fetal ovary through an interplay with FOXL2. | 1.01e-05 | 21 | 70 | 3 | 31712577 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 19585539 | ||
| Pubmed | cdx4/lacZ and cdx2/lacZ protein gradients formed by decay during gastrulation in the mouse. | 1.20e-05 | 3 | 70 | 2 | 16281167 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 20933081 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 9196325 | ||
| Pubmed | Cdx gene deficiency compromises embryonic hematopoiesis in the mouse. | 1.20e-05 | 3 | 70 | 2 | 18511567 | |
| Pubmed | Mds1CreERT2, an inducible Cre allele specific to adult-repopulating hematopoietic stem cells. | 1.20e-05 | 3 | 70 | 2 | 34407416 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 19115250 | ||
| Interaction | FBXW12 interactions | 5.75e-08 | 12 | 68 | 4 | int:FBXW12 | |
| Interaction | CBFB interactions | 1.38e-06 | 104 | 68 | 6 | int:CBFB | |
| Interaction | TLE3 interactions | 4.65e-06 | 376 | 68 | 9 | int:TLE3 | |
| Interaction | GATA2 interactions | 4.80e-06 | 199 | 68 | 7 | int:GATA2 | |
| Interaction | PRDM1 interactions | 9.46e-06 | 84 | 68 | 5 | int:PRDM1 | |
| Interaction | KLF3 interactions | 1.17e-05 | 228 | 68 | 7 | int:KLF3 | |
| Interaction | EGR2 interactions | 2.42e-05 | 171 | 68 | 6 | int:EGR2 | |
| Interaction | PAX8 interactions | 3.66e-05 | 111 | 68 | 5 | int:PAX8 | |
| Interaction | PML interactions | NCOR1 TBX3 ZNF609 FBXO3 ZNF608 ZNF318 RUNX2 RUNX1 RUNX3 PIAS1 AHDC1 TBX2 | 5.99e-05 | 933 | 68 | 12 | int:PML |
| Interaction | FEV interactions | 6.32e-05 | 203 | 68 | 6 | int:FEV | |
| Interaction | SMG7 interactions | 9.88e-05 | 319 | 68 | 7 | int:SMG7 | |
| Interaction | ERG interactions | 1.06e-04 | 223 | 68 | 6 | int:ERG | |
| Interaction | AR interactions | NCOR1 TBX3 ZNF609 ZBTB32 ZNF608 ZNF318 RUNX2 RUNX1 PIAS1 PABPC1 AHDC1 PRRC2B | 1.08e-04 | 992 | 68 | 12 | int:AR |
| Interaction | TEAD4 interactions | 1.27e-04 | 76 | 68 | 4 | int:TEAD4 | |
| Cytoband | 13q12.3 | 5.19e-04 | 22 | 70 | 2 | 13q12.3 | |
| Cytoband | 17q23.2 | 1.17e-03 | 33 | 70 | 2 | 17q23.2 | |
| Cytoband | 9q33.2 | 1.64e-03 | 39 | 70 | 2 | 9q33.2 | |
| GeneFamily | HOXL subclass homeoboxes | 3.54e-04 | 52 | 48 | 3 | 518 | |
| GeneFamily | T-boxes | 1.03e-03 | 18 | 48 | 2 | 766 | |
| GeneFamily | Neuroblastoma breakpoint family | 1.69e-03 | 23 | 48 | 2 | 662 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.15e-03 | 26 | 48 | 2 | 253 | |
| GeneFamily | Olfactory receptors, family 1 | 5.05e-03 | 40 | 48 | 2 | 147 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 5.66e-07 | 191 | 70 | 6 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-07 | 192 | 70 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 6.78e-07 | 197 | 70 | 6 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.29e-06 | 175 | 70 | 5 | 0c6cf88818037bef67211c1a8fcb1e7d47711c1d | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.00e-06 | 178 | 70 | 5 | 4b3ea0921bc598ebb9f63780ecdf8ad4349f3666 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.25e-06 | 179 | 70 | 5 | 9fd9b136ecbcbd4e4f0d5875ede98d8d48608afb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.25e-06 | 179 | 70 | 5 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | IPF-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.00e-05 | 182 | 70 | 5 | f91bb45baaec76cb3bb26eedbcf0709b2492e93f | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-05 | 183 | 70 | 5 | 2d0d3b486498a7903fa9a1f48b189291da49c430 | |
| ToppCell | IPF-Lymphoid-ILC_A|IPF / Disease state, Lineage and Cell class | 1.03e-05 | 183 | 70 | 5 | 49bfeaae13eb236f61a5486ee75c39789936bb8a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-05 | 186 | 70 | 5 | 428b4cbee3d3ab666cab2fc2d9c815318359e458 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.20e-05 | 189 | 70 | 5 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.20e-05 | 189 | 70 | 5 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 189 | 70 | 5 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-05 | 189 | 70 | 5 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 190 | 70 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-05 | 190 | 70 | 5 | 05e6af222d0ad97cb69f399a96c9038f9dd989b9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 190 | 70 | 5 | 116314a27064d3005d950c9a9163b79ea438707b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 190 | 70 | 5 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 1.23e-05 | 190 | 70 | 5 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 190 | 70 | 5 | 6b704deeb44e1ffa10e604d0e5612b022f6cd9a6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-05 | 191 | 70 | 5 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 191 | 70 | 5 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-05 | 191 | 70 | 5 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 191 | 70 | 5 | 1a2d5fec2bea96da2154b0aed252f1bb35102f6e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-05 | 191 | 70 | 5 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-05 | 191 | 70 | 5 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 191 | 70 | 5 | 326b4541069efedc8ab409f85bb11f77346dda90 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 191 | 70 | 5 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 192 | 70 | 5 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 193 | 70 | 5 | 12f1333f11e6c262954ad7912d8fd2962ab06d25 | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 1.33e-05 | 193 | 70 | 5 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 193 | 70 | 5 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-MAIT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 193 | 70 | 5 | 9aeb34d7a24f84abff38d7b8cf0ec707c08eb27f | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-05 | 193 | 70 | 5 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-05 | 194 | 70 | 5 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-05 | 194 | 70 | 5 | 937ee85ffd50869b60f0f6e91017ab77e8b24c0b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 194 | 70 | 5 | 633fe72cc8a489abde12428e326478409ca03263 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 194 | 70 | 5 | 87a86df0b542f287b0b20f4a4b1a37002271671d | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 1.36e-05 | 194 | 70 | 5 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.43e-05 | 196 | 70 | 5 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | T_cells-CCR7+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.47e-05 | 197 | 70 | 5 | 904430779c42b51d3eec62cf0cdd501b17058d8b | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-MAIT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 197 | 70 | 5 | b8535734a61b718ff17a6a374182f30c1d3bc86f | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 198 | 70 | 5 | 1eb49b853a9e144e840c660060473fc7873f6478 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-05 | 198 | 70 | 5 | d7e15e61b6018e4c36461c9471ee29601929925c | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-05 | 198 | 70 | 5 | 5d42f4fda2081ea3e9f62a00e7eea702e0d0be7d | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-05 | 198 | 70 | 5 | 99d6a64f3410dae3019161feef20a8f06081a24b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Late_airway_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.54e-05 | 199 | 70 | 5 | 494461665f945ce6c97299c58f7785e90dec5812 | |
| ToppCell | Biopsy_Other_PF-Endothelial-Lymphatic_Endothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.54e-05 | 199 | 70 | 5 | aa80c77fe4f6a141c780c7d8ecfff5d5a1c3b845 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_CD56bright|Control / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | d843fe0781c7699afead4429c526441c6fdb8cba | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD8+_Tem|Influenza_Severe / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | 06d80a7aff4b168b131c80750c335215b0fcff3f | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.58e-05 | 200 | 70 | 5 | a1a4c5cbf4c009d4c09699a16e2d5b814a8751ca | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Intermediate|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.64e-05 | 109 | 70 | 4 | 48f675d36fece070410eb9cfe64805f4629e290f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 6.83e-05 | 139 | 70 | 4 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.71e-05 | 148 | 70 | 4 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.41e-05 | 151 | 70 | 4 | 563439b0278776b82c1836c3de9fa80d1a4109af | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / disease group, cell group and cell class | 1.15e-04 | 159 | 70 | 4 | 9e2067f0d76769717f7048dab505fadd36bbb83e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.15e-04 | 159 | 70 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 161 | 70 | 4 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 1.21e-04 | 161 | 70 | 4 | a1f10e04836848b1deaf295fae033f54d1572fcd | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 162 | 70 | 4 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | Healthy-NK_CD56bright|Healthy / disease group, cell group and cell class | 1.29e-04 | 164 | 70 | 4 | ed193211965accba60a256d3e6c159f0fc911d8b | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 165 | 70 | 4 | 8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296 | |
| ToppCell | Endothelial-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.32e-04 | 165 | 70 | 4 | 10087d8bd2985906ef19547fe77eb178ae5e1638 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 165 | 70 | 4 | 8dbd03795fff060cd2e4d5d97348f5b63515e030 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 165 | 70 | 4 | 5fc5e34cc805df44c020256729256ef761790152 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-04 | 165 | 70 | 4 | 5f606959a060b1ae241217889560c6761ac73bbb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 165 | 70 | 4 | 64c7c45383afde1d050934938705e47aa615755f | |
| ToppCell | Healthy-NK_CD56bright|World / disease group, cell group and cell class | 1.39e-04 | 167 | 70 | 4 | ab7a570a75ee2018b9fe886cdec79cda27f1563f | |
| ToppCell | Severe-Lymphoid-NK-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.39e-04 | 167 | 70 | 4 | 8d41015871616ab7eced5104cd8f70d0efe504f2 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 168 | 70 | 4 | 6c758eb120faf06ff72d157b495e399191c79ec9 | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.45e-04 | 169 | 70 | 4 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 169 | 70 | 4 | 2ad6ab74788c8738c9087811688a6128e5fa882a | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 169 | 70 | 4 | 3e608377b57e7f309d243467668c50abb499fcfe | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 170 | 70 | 4 | 4848965bc7e9356c6601bb41eeea1553d2eea87e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 170 | 70 | 4 | b5b47fe42617a4c2ebb49c8ed55db3926213a75a | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|World / disease group, cell group and cell class | 1.49e-04 | 170 | 70 | 4 | caa6a534c1e9639caced9a51680f5c905f061bcc | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 171 | 70 | 4 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 171 | 70 | 4 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 171 | 70 | 4 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 171 | 70 | 4 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-04 | 171 | 70 | 4 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 171 | 70 | 4 | 801893c318f7b1abc8d97bac86a00974f910a71c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-04 | 172 | 70 | 4 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 1.55e-04 | 172 | 70 | 4 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.59e-04 | 173 | 70 | 4 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | ASK428-Immune-B_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.62e-04 | 174 | 70 | 4 | b5a7a612a515736cf3489afd0f6ad2054d54526f | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.62e-04 | 174 | 70 | 4 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | Healthy_Control-Lymphoid-NK-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.62e-04 | 174 | 70 | 4 | 5dddb822fa51b4020e4d9318acacd19c726091d6 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.62e-04 | 174 | 70 | 4 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 174 | 70 | 4 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 174 | 70 | 4 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.66e-04 | 175 | 70 | 4 | 0ed053aa8353c72ff37fee830672704a3ddc7d85 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.66e-04 | 175 | 70 | 4 | 0124a3c4696b39cee8b566e94603d1d3d128bfa5 | |
| ToppCell | COVID-19_Convalescent|World / Disease Group and Platelet Clusters | 1.66e-04 | 175 | 70 | 4 | e9b1faa4c85537f30306619a2f3ada6c8ef0ac6c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-04 | 175 | 70 | 4 | e219b61d6bc078d44ea7d06191d3462654d857a1 | |
| ToppCell | ASK428-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.66e-04 | 175 | 70 | 4 | e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 175 | 70 | 4 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-04 | 175 | 70 | 4 | bd16c80418bf71127e6f1e50edf83967c9218b42 | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.66e-04 | 175 | 70 | 4 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.46e-06 | 182 | 70 | 7 | 3630_DN | |
| Drug | A-K-V | 5.01e-06 | 37 | 70 | 4 | CID011840919 | |
| Disease | permanent dental caries | 1.03e-04 | 7 | 66 | 2 | EFO_0600096 | |
| Disease | Calcium channel blocker use measurement | 1.17e-04 | 213 | 66 | 5 | EFO_0009930 | |
| Disease | fibromuscular dysplasia | 1.33e-04 | 44 | 66 | 3 | EFO_1000938 | |
| Disease | Odontome | 2.19e-04 | 10 | 66 | 2 | C0524730 | |
| Disease | Tooth Abnormalities | 2.19e-04 | 10 | 66 | 2 | C0040427 | |
| Disease | brain measurement, neuroimaging measurement | 2.27e-04 | 550 | 66 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | stomach cancer (is_marker_for) | 2.94e-04 | 142 | 66 | 4 | DOID:10534 (is_marker_for) | |
| Disease | calcium measurement | 5.02e-04 | 628 | 66 | 7 | EFO_0004838 | |
| Disease | neuroimaging measurement | SEMA3A NCOR1 NEUROD2 ZBTB32 ADAMTS20 CC2D2A RUNX2 MAP3K7 AGBL1 | 6.02e-04 | 1069 | 66 | 9 | EFO_0004346 |
| Disease | hypertension | 6.28e-04 | 307 | 66 | 5 | EFO_0000537 | |
| Disease | Glioblastoma | 7.49e-04 | 79 | 66 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 8.95e-04 | 84 | 66 | 3 | C0334588 | |
| Disease | left ventricular structural measurement | 1.02e-03 | 88 | 66 | 3 | EFO_0008205 | |
| Disease | myeloproliferative disorder | 1.43e-03 | 25 | 66 | 2 | EFO_0004251 | |
| Disease | sensory perception of bitter taste | 1.55e-03 | 26 | 66 | 2 | GO_0050913 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 1.67e-03 | 27 | 66 | 2 | EFO_0004629, EFO_0004630 | |
| Disease | white matter microstructure measurement | 1.81e-03 | 390 | 66 | 5 | EFO_0005674 | |
| Disease | ceramide measurement | 1.92e-03 | 235 | 66 | 4 | EFO_0010222 | |
| Disease | cortical thickness, neuroimaging measurement | 1.94e-03 | 110 | 66 | 3 | EFO_0004346, EFO_0004840 | |
| Disease | Glioblastoma Multiforme | 2.00e-03 | 111 | 66 | 3 | C1621958 | |
| Disease | obsessive-compulsive symptom measurement | 2.20e-03 | 31 | 66 | 2 | EFO_0007802 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IYHLASPASPPNYMY | 156 | Q8NBZ7 | |
| PAAAMGYSSPADYHP | 101 | Q99626 | |
| AAPAFSHYMGYPHMP | 46 | O14627 | |
| YPFSYLFRAAHVLMP | 471 | P49902 | |
| VYAQRAPYHPDGVFM | 161 | O94923 | |
| DTAYRYPGFMPQAHP | 1561 | Q5TGY3 | |
| GPYREDHPNPAMAYA | 176 | Q8IUZ5 | |
| LEPMPFRTHYRFTAY | 71 | P59510 | |
| VPFHDPYLYMAKARR | 506 | Q96MI9 | |
| AHYEVPPTFYRSAML | 751 | Q5JR59 | |
| QYHMGYFRDSPDEFP | 126 | Q9NWY4 | |
| PSYPMASLYVGDLHP | 6 | P11940 | |
| QHARPTPFFMDPIYR | 816 | Q03112 | |
| PGPDAMRYSLYQSPH | 236 | Q96JH8 | |
| FPLPAAFYHPVRYMF | 46 | Q9UMS0 | |
| EYPPADPSEHMYAPK | 471 | Q09327 | |
| GCRDASLNHPPYMPY | 2331 | O43451 | |
| SLNHPPYMPYLESRD | 2336 | O43451 | |
| SSPFGPFYRRHTPYM | 11 | O43679 | |
| IFPARDTYHPMSEYP | 1196 | P15941 | |
| YRPVHYFRPMVAATS | 371 | Q9BRR8 | |
| PPHYFFTYRIRIEMS | 301 | Q9UK99 | |
| YSPPAYHMHVFDRPY | 131 | Q9NWM3 | |
| HLMRYFPGADEPLQY | 286 | O43318 | |
| IYHPFDPVAYRIEPM | 536 | O94830 | |
| PPAAAAMSGLYHPYV | 86 | P28356 | |
| VFYYHIDPFQPMSGR | 76 | O60487 | |
| HPAFAPLYFPMELHR | 91 | P30519 | |
| PEDYPRFFHMHPRTA | 331 | Q96QU1 | |
| PFPFDPDKHYLMYEH | 1641 | Q9Y2I7 | |
| PPYTMCFRVKFYPHE | 101 | A2A2Y4 | |
| FPTHLYPGVYPAMRL | 161 | Q8IV32 | |
| AEDMYRPHPGFYRPR | 206 | Q9UF02 | |
| DYRFSGFPLHMPYSE | 1556 | Q9P2K1 | |
| FIPPSMYRATHYPPY | 261 | Q9C0J1 | |
| FYMYEGPAPRIRAHN | 396 | O14638 | |
| PVYWLPSIHRYMYPE | 211 | A4D1U4 | |
| EEEMYRPHPAFYRPR | 206 | P62955 | |
| ALQRMFPSPYFYHPS | 306 | Q9NY43 | |
| FPSPYFYHPSLLGSM | 311 | Q9NY43 | |
| DYFIHYFAPRGLPPM | 266 | Q6UXX5 | |
| YGAPLPPAERMEHYV | 76 | O43921 | |
| YSDPRLHTPMYFFLS | 51 | Q8NGR5 | |
| IYSDPRLHTPMYFFL | 86 | Q8NGR2 | |
| SDPRMHYPGAFTYSP | 316 | Q01196 | |
| RFSNPRMHYPATFTY | 386 | Q13950 | |
| PRMHYPGAMSAAFPY | 266 | Q13761 | |
| AYHPFLPHRAPDFAM | 16 | O15119 | |
| YMYQHISPDLSRRFP | 131 | Q8N9U0 | |
| PSMYFELPDSFQHYR | 1056 | P0DPF3 | |
| PSMYFELPDSFQHYR | 866 | Q5TI25 | |
| AMPFHRALDPAAAAY | 1571 | O75376 | |
| SYPGAYPSQHMAFRP | 146 | Q8WV41 | |
| TFARSHPAMYNPVFP | 401 | Q14563 | |
| DYRHPFHMTPMPYDL | 526 | O75925 | |
| MPHSYPYVALQLFGR | 76 | Q9UIY3 | |
| SHPMLRFDYVPSFLY | 921 | Q8TEV9 | |
| MPDPAAHLPFFYGSI | 1 | P43403 | |
| YEHRFAPFNSVMTPP | 616 | Q5VZE5 | |
| MAYHPFHAPRPADFP | 11 | Q13207 | |
| QPRHGAPMYRYSFAS | 176 | Q8TB61 | |
| SYDPNHPSYRSMPAV | 1236 | O15014 | |
| SIAVYYDNPHMVPPD | 76 | Q9Y6I9 | |
| NVYHPPTYHDMLPAF | 271 | Q5JSZ5 | |
| VYSAFNLLMHYPPPS | 121 | P36402 | |
| YPQMYDPSHPAYRAV | 1351 | Q9ULD9 | |
| APRPYPAHYMDTAIQ | 476 | Q9Y2L5 | |
| PVPDDRYHAIYFAML | 61 | Q7RTT9 | |
| LLMPPRYGIPFYHST | 266 | Q9Y2Y4 | |
| PAIPPASFDAYRHYM | 781 | Q5VUA4 | |
| MHPYPYPCSRLAGAQ | 236 | Q15784 | |
| PDLEKSYSFMPHYPS | 271 | Q9HD90 |